These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 16525683)
1. Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro. Tanaka T; Bai T; Yukawa K; Umesaki N Oncol Rep; 2006 Apr; 15(4):939-47. PubMed ID: 16525683 [TBL] [Abstract][Full Text] [Related]
2. Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells. Tanaka T; Bai T; Yukawa K; Utsunomiya T; Umesaki N Oncol Rep; 2005 Oct; 14(4):941-8. PubMed ID: 16142355 [TBL] [Abstract][Full Text] [Related]
3. Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro. Tanaka T; Yukawa K; Umesaki N Oncol Rep; 2005 Nov; 14(5):1365-9. PubMed ID: 16211310 [TBL] [Abstract][Full Text] [Related]
4. Radiation reduces pirarubicin sensitivity in human cervical squamous cell carcinoma cells. Tanaka T; Umesaki N Oncol Rep; 2005 Jun; 13(6):1165-8. PubMed ID: 15870938 [TBL] [Abstract][Full Text] [Related]
5. Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro. Tanaka T; Yukawa K; Umesaki N Eur J Gynaecol Oncol; 2006; 27(3):243-6. PubMed ID: 16800250 [TBL] [Abstract][Full Text] [Related]
6. Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells. Tanaka T; Bai T; Toujima S; Utsunomiya T; Matsuoka T; Kobayashi A; Yamamoto M; Sasaki N; Tanizaki Y; Utsunomiya H; Tanaka J; Yukawa K Oncol Rep; 2012 Apr; 27(4):1292-8. PubMed ID: 22246465 [TBL] [Abstract][Full Text] [Related]
7. Effects of mitomycin C on radiation-induced cell death in human cervical squamous cell carcinomas. Tanaka T; Umesaki N Eur J Gynaecol Oncol; 2005; 26(4):411-4. PubMed ID: 16122190 [TBL] [Abstract][Full Text] [Related]
8. Radiation enhances cisplatin-sensitivity in human cervical squamous cancer cells in vitro. Tanaka T; Yukawa K; Umesaki N Eur J Gynaecol Oncol; 2005; 26(4):431-3. PubMed ID: 16122195 [TBL] [Abstract][Full Text] [Related]
9. Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro. Tanaka T; Yukawa K; Umesaki N Eur J Gynaecol Oncol; 2007; 28(5):352-5. PubMed ID: 17966212 [TBL] [Abstract][Full Text] [Related]
10. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma]. Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032 [TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of cancer cells that survived anticancer drug treatment. Tanaka T; Chang L; Umesaki N; Ogita S Osaka City Med J; 1997 Dec; 43(2):259-65. PubMed ID: 9540347 [TBL] [Abstract][Full Text] [Related]
12. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells. Tanaka T; Bai T; Yukawa K; Umesaki N Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines. Ling YH; Donato NJ; Perez-Soler R Cancer Chemother Pharmacol; 2001 Jun; 47(6):473-80. PubMed ID: 11459199 [TBL] [Abstract][Full Text] [Related]
14. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix. Lin JC; Ho ES; Jan JS; Yang CH; Liu FS Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094 [TBL] [Abstract][Full Text] [Related]
15. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. Bai T; Tanaka T; Yukawa K; Umesaki N Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806 [TBL] [Abstract][Full Text] [Related]
16. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. Xie L; Song X; Yu J; Wei L; Song B; Wang X; Lv L J Exp Clin Cancer Res; 2009 May; 28(1):68. PubMed ID: 19470182 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix]. Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134 [TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study. Zhang MQ; Liu SP; Wang XE Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507 [TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells. Tanaka T; Toujima S; Tanaka J Int J Oncol; 2012 Nov; 41(5):1837-44. PubMed ID: 22923148 [TBL] [Abstract][Full Text] [Related]
20. Cellular response to chemotherapy and radiation in cervical cancer. Saxena A; Yashar C; Taylor DD; Gercel-Taylor C Am J Obstet Gynecol; 2005 May; 192(5):1399-403. PubMed ID: 15902120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]